Literature DB >> 12361391

Use of the Kohonen neural network for rapid screening of ex vivo anti-HIV activity of styrylquinolines.

Jaroslaw Polanski1, Fatima Zouhiri, Laurence Jeanson, Didier Desmaële, Jean d'Angelo, Jean-François Mouscadet, Rafal Gieleciak, Johann Gasteiger, Marc Le Bret.   

Abstract

Using the Kohonen neural network, the electrostatic potentials on the molecular surfaces of 14 styrylquinoline derivatives were drawn as comparative two-dimensional maps and compared with their known human immunodeficiency virus (HIV)-1 replication blocking potency in cells. A feature of the potential map was discovered to be related with the HIV-1 blocking activity and was used to unmask the activity of further five analogues, previously described but whose cytotoxicity precluded an estimation of their activity, and to predict the activity of 10 new compounds while the experimental data were unknown. The measurements performed later turned out to agree with the predictions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361391     DOI: 10.1021/jm020845g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

Review 1.  Comparative molecular surface analysis: a novel tool for drug design and molecular diversity studies.

Authors:  Jaroslaw Polanski; Rafal Gieleciak
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

2.  On the interpretation and interpretability of quantitative structure-activity relationship models.

Authors:  Rajarshi Guha
Journal:  J Comput Aided Mol Des       Date:  2008-09-11       Impact factor: 3.686

3.  In vitro activities of new 2-substituted quinolines against Leishmania donovani.

Authors:  Philippe M Loiseau; Suman Gupta; Aditya Verma; Saumya Srivastava; S K Puri; Faten Sliman; Marie Normand-Bayle; Didier Desmaele
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

4.  Microwave-assisted, rapid synthesis of 2-vinylquinolines and evaluation of their antimalarial activity.

Authors:  Guang Huang; Claribel Murillo Solano; Yuxin Su; Nameer Ezzat; Shino Matsui; Liuyu Huang; Debopam Chakrabarti; Yu Yuan
Journal:  Tetrahedron Lett       Date:  2019-05-28       Impact factor: 2.415

5.  Synthesis, Structure-Activity Relationship, and Antimalarial Efficacy of 6-Chloro-2-arylvinylquinolines.

Authors:  Guang Huang; Claribel Murillo Solano; Joel Melendez; Justin Shaw; Jennifer Collins; Robert Banks; Arash Keshavarzi Arshadi; Rachasak Boonhok; Hui Min; Jun Miao; Debopam Chakrabarti; Yu Yuan
Journal:  J Med Chem       Date:  2020-10-06       Impact factor: 7.446

6.  Rhodamine Based Turn-On Sensors for Ni(2+) and Cr(3+) in Organic Media: Detecting CN(-) via the Metal Displacement Approach.

Authors:  Aruna J Weerasinghe; Agozie N Oyeamalu; Fasil A Abebe; Andre R Venter; Ekkehard Sinn
Journal:  J Fluoresc       Date:  2016-03-19       Impact factor: 2.217

7.  Quionolone carboxylic acid derivatives as HIV-1 integrase inhibitors: Docking-based HQSAR and topomer CoMFA analyses.

Authors:  Jianbo Tong; Pei Zhan; Xiang Simon Wang; Yingji Wu
Journal:  J Chemom       Date:  2017-08-29       Impact factor: 2.467

8.  Experimental and theoretical study of o-substituent effect on the fluorescence of 8-hydroxyquinoline.

Authors:  Mohie E M Zayed; Reda M El-Shishtawy; Shaaban A Elroby; Abdullah Y Obaid; Zahra M Al-amshany
Journal:  Int J Mol Sci       Date:  2015-02-10       Impact factor: 5.923

9.  Design, synthesis and anti-HIV integrase evaluation of N-(5-chloro-8-hydroxy-2-styrylquinolin-7-yl)benzenesulfonamide derivatives.

Authors:  Zi-Guo Jiao; Hong-Qiu He; Cheng-Chu Zeng; Jian-Jun Tan; Li-Ming Hu; Cun-Xin Wang
Journal:  Molecules       Date:  2010-03-16       Impact factor: 4.411

10.  Investigating biological activity spectrum for novel styrylquinazoline analogues.

Authors:  Josef Jampilek; Robert Musiol; Jacek Finster; Matus Pesko; James Carroll; Katarina Kralova; Marcela Vejsova; Jim O'Mahony; Aidan Coffey; Jiri Dohnal; Jaroslaw Polanski
Journal:  Molecules       Date:  2009-10-23       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.